352 related articles for article (PubMed ID: 25427142)
1. The diversity of mutations and clinical outcomes for ELANE-associated neutropenia.
Makaryan V; Zeidler C; Bolyard AA; Skokowa J; Rodger E; Kelley ML; Boxer LA; Bonilla MA; Newburger PE; Shimamura A; Zhu B; Rosenberg PS; Link DC; Welte K; Dale DC
Curr Opin Hematol; 2015 Jan; 22(1):3-11. PubMed ID: 25427142
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia.
Germeshausen M; Deerberg S; Peter Y; Reimer C; Kratz CP; Ballmaier M
Hum Mutat; 2013 Jun; 34(6):905-14. PubMed ID: 23463630
[TBL] [Abstract][Full Text] [Related]
3. Four novel ELANE mutations in patients with congenital neutropenia.
Kurnikova M; Maschan M; Dinova E; Shagina I; Finogenova N; Mamedova E; Polovtseva T; Shagin D; Shcherbina A
Pediatr Blood Cancer; 2011 Aug; 57(2):332-5. PubMed ID: 21425445
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of SCN and CyN induced by ELANE mutations: a systematic review.
Xiao Y; Wang N; Jin X; Liu A; Zhang Z
Front Immunol; 2024; 15():1349919. PubMed ID: 38840904
[TBL] [Abstract][Full Text] [Related]
5. ELANE mutant-specific activation of different UPR pathways in congenital neutropenia.
Nustede R; Klimiankou M; Klimenkova O; Kuznetsova I; Zeidler C; Welte K; Skokowa J
Br J Haematol; 2016 Jan; 172(2):219-27. PubMed ID: 26567890
[TBL] [Abstract][Full Text] [Related]
6. A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.
Qiu Y; Zhang Y; Hu N; Dong F
J Biol Chem; 2017 Feb; 292(8):3496-3505. PubMed ID: 28073911
[TBL] [Abstract][Full Text] [Related]
7. Screening for ELANE, HAX1 and GFI1 gene mutations in children with neutropenia and clinical characterization of two novel mutations in ELANE gene.
Komvilaisak P; Yudhasompop N; Kanchanakamhaeng K; Hongeng S; Pakakasama S; Anurathapan U; Pongphitcha P; Songdej D; Sasanakul W; Sirachainan N
BMC Pediatr; 2023 Nov; 23(1):592. PubMed ID: 37993852
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of
Arun AK; Senthamizhselvi A; Hemamalini S; Edison ES; Korula A; Fouzia NA; George B; Mathews V; Balasubramanian P
J Clin Pathol; 2018 Dec; 71(12):1046-1050. PubMed ID: 30171085
[TBL] [Abstract][Full Text] [Related]
9. ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.
Horwitz MS; Corey SJ; Grimes HL; Tidwell T
Hematol Oncol Clin North Am; 2013 Feb; 27(1):19-41, vii. PubMed ID: 23351986
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia.
Xia J; Bolyard AA; Rodger E; Stein S; Aprikyan AA; Dale DC; Link DC
Br J Haematol; 2009 Nov; 147(4):535-42. PubMed ID: 19775295
[TBL] [Abstract][Full Text] [Related]
11. Elastase inhibitors as potential therapies for
Makaryan V; Kelley ML; Fletcher B; Bolyard AA; Aprikyan AA; Dale DC
J Leukoc Biol; 2017 Oct; 102(4):1143-1151. PubMed ID: 28754797
[TBL] [Abstract][Full Text] [Related]
12. Game of clones: the genomic evolution of severe congenital neutropenia.
Touw IP
Hematology Am Soc Hematol Educ Program; 2015; 2015():1-7. PubMed ID: 26637693
[TBL] [Abstract][Full Text] [Related]
13. Inducible expression of a disease-associated
Garg B; Mehta HM; Wang B; Kamel R; Horwitz MS; Corey SJ
J Biol Chem; 2020 May; 295(21):7492-7500. PubMed ID: 32299910
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of severe congenital neutropenia caused by novel ELANE gene mutations.
Shu Z; Li XH; Bai XM; Zhang ZY; Jiang LP; Tang XM; Zhao XD
Pediatr Infect Dis J; 2015 Feb; 34(2):203-7. PubMed ID: 25162927
[TBL] [Abstract][Full Text] [Related]
15. Paternal Somatic Mosaicism of a Novel Frameshift Mutation in ELANE Causing Severe Congenital Neutropenia.
Kim HJ; Song MJ; Lee KO; Kim SH; Kim HJ
Pediatr Blood Cancer; 2015 Dec; 62(12):2229-31. PubMed ID: 26174650
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9-Mediated ELANE Mutation Correction in Hematopoietic Stem and Progenitor Cells to Treat Severe Congenital Neutropenia.
Tran NT; Graf R; Wulf-Goldenberg A; Stecklum M; Strauß G; Kühn R; Kocks C; Rajewsky K; Chu VT
Mol Ther; 2020 Dec; 28(12):2621-2634. PubMed ID: 32822592
[TBL] [Abstract][Full Text] [Related]
17. Cyclic Neutropenia From a Novel Mutation Ala57Asp of ELANE: Phenotypic Variability in Neutropenia From Mutated Ala57 Residue.
Park CH; Park S; Kim YJ; Kim SH; Kim HJ
J Pediatr Hematol Oncol; 2020 May; 42(4):e231-e234. PubMed ID: 31658467
[TBL] [Abstract][Full Text] [Related]
18. Mosaicism of an ELANE mutation in an asymptomatic mother in a familial case of cyclic neutropenia.
Hirata O; Okada S; Tsumura M; Karakawa S; Matsumura I; Kimura Y; Maihara T; Yasunaga S; Takihara Y; Ohara O; Kobayashi M
J Clin Immunol; 2015 Jul; 35(5):512-6. PubMed ID: 25912133
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the ELANE gene are associated with development of periodontitis in patients with severe congenital neutropenia.
Ye Y; Carlsson G; Wondimu B; Fahlén A; Karlsson-Sjöberg J; Andersson M; Engstrand L; Yucel-Lindberg T; Modéer T; Pütsep K
J Clin Immunol; 2011 Dec; 31(6):936-45. PubMed ID: 21796505
[TBL] [Abstract][Full Text] [Related]
20. Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes.
Newburger PE; Pindyck TN; Zhu Z; Bolyard AA; Aprikyan AA; Dale DC; Smith GD; Boxer LA
Pediatr Blood Cancer; 2010 Aug; 55(2):314-7. PubMed ID: 20582973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
